|
US2802005A
(en)
|
|
1957-08-06 |
|
S-eluorourace |
|
US729332A
(en)
*
|
1902-07-21 |
1903-05-26 |
Frank C Guss |
Animal catching and holding device.
|
|
US2885396A
(en)
|
1957-03-21 |
1959-05-05 |
Heidelberger Charles |
N-glycosides of 5-fluorouracil
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3885035A
(en)
|
1972-04-05 |
1975-05-20 |
Sandoz Ag |
Method for treating arrhythmia by using 1,4-bis(4 quinazolinyl) piperazines
|
|
CH605550A5
(OSRAM)
|
1972-06-08 |
1978-09-29 |
Research Corp |
|
|
US3956495A
(en)
|
1973-10-30 |
1976-05-11 |
Eli Lilly And Company |
2,4-Diaminoquinazolines as antithrombotic agents
|
|
US3966936A
(en)
|
1974-02-21 |
1976-06-29 |
Pfizer Inc. |
Piperazino quinazoline bronchodilators
|
|
US4060615A
(en)
|
1976-02-18 |
1977-11-29 |
Mead Johnson & Company |
2-Piperazinyl-6,7-dimethoxyquinazolines
|
|
JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
|
|
JPS562968A
(en)
|
1979-06-21 |
1981-01-13 |
Mitsubishi Yuka Yakuhin Kk |
Novel pyrimidine derivative
|
|
US5260291A
(en)
|
1981-08-24 |
1993-11-09 |
Cancer Research Campaign Technology Limited |
Tetrazine derivatives
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
DE3587500T2
(de)
|
1984-12-04 |
1993-12-16 |
Lilly Co Eli |
Tumorbehandlung bei Säugetieren.
|
|
US4749704A
(en)
|
1985-03-07 |
1988-06-07 |
Sankyo Company Limited |
Cyclopenta[d]pyrimidine derivatives and use as antidepressants
|
|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
WO1987004928A1
(fr)
|
1986-02-24 |
1987-08-27 |
Mitsui Petrochemical Industries, Ltd. |
Agents therapeutiques de la neuropathie
|
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US4871739A
(en)
|
1987-01-21 |
1989-10-03 |
Merck & Co., Inc. |
Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents
|
|
US4889856A
(en)
|
1987-08-31 |
1989-12-26 |
Merck & Co., Inc. |
7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as β-blockers
|
|
US4994464A
(en)
|
1987-08-31 |
1991-02-19 |
Merck & Co., Inc. |
Piperazinylpyrimidines as β-adrenergic receptor blockers
|
|
MX19185A
(es)
|
1989-01-20 |
1993-12-01 |
Pfizer |
Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
|
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
|
US20030206899A1
(en)
|
1991-03-29 |
2003-11-06 |
Genentech, Inc. |
Vascular endothelial cell growth factor antagonists
|
|
EP0940468A1
(en)
|
1991-06-14 |
1999-09-08 |
Genentech, Inc. |
Humanized antibody variable domain
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US5714512A
(en)
|
1991-07-08 |
1998-02-03 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
|
US5750561A
(en)
|
1991-07-08 |
1998-05-12 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
|
US5698582A
(en)
|
1991-07-08 |
1997-12-16 |
Rhone-Poulenc Rorer S.A. |
Compositions containing taxane derivatives
|
|
US5604213A
(en)
|
1992-03-31 |
1997-02-18 |
British Technology Group Limited |
17-substituted steroids useful in cancer treatment
|
|
WO1994007890A1
(fr)
|
1992-10-05 |
1994-04-14 |
Ube Industries, Ltd. |
Compose pyrimidine
|
|
ATE348110T1
(de)
|
1992-10-28 |
2007-01-15 |
Genentech Inc |
Hvegf rezeptor als vegf antagonist
|
|
FR2698543B1
(fr)
|
1992-12-02 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions à base de taxoides.
|
|
WO1995003286A1
(en)
|
1993-07-23 |
1995-02-02 |
The Green Cross Corporation |
Triazole derivative and pharmaceutical use thereof
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
GB9416189D0
(en)
|
1994-08-10 |
1994-09-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP2896532B2
(ja)
|
1994-08-13 |
1999-05-31 |
ユーハン コーポレーション |
新規なピリミジン誘導体およびその製造方法
|
|
US5543523A
(en)
|
1994-11-15 |
1996-08-06 |
Regents Of The University Of Minnesota |
Method and intermediates for the synthesis of korupensamines
|
|
US5525625A
(en)
|
1995-01-24 |
1996-06-11 |
Warner-Lambert Company |
2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders
|
|
IL117645A
(en)
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
|
JPH08336393A
(ja)
|
1995-04-13 |
1996-12-24 |
Mitsubishi Chem Corp |
光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US7294332B2
(en)
*
|
1995-10-04 |
2007-11-13 |
Schering Corporation |
Combination therapy (temozolomide and α-IFN) for advanced cancer
|
|
ZA979961B
(en)
|
1996-11-15 |
1999-05-05 |
Lilly Co Eli |
5-HT1F agonists
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
SI1695985T1
(sl)
|
1997-04-07 |
2011-06-30 |
Genentech Inc |
Postopki za tvorbo humaniziranih protiteles z naključno mutagenezo
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
WO1998045331A2
(en)
|
1997-04-07 |
1998-10-15 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
AU756586C
(en)
|
1997-07-01 |
2004-01-29 |
Warner-Lambert Company |
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
|
|
ES2229515T3
(es)
|
1997-07-01 |
2005-04-16 |
Warner-Lambert Company Llc |
Derivados 4-bromo o 4-yodo del acido fenilamino benzhidroxamico y su uso como inhibidores de la mek.
|
|
US6506798B1
(en)
|
1997-07-01 |
2003-01-14 |
Warner-Lambert Company |
4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
|
|
US6821963B2
(en)
|
1997-07-01 |
2004-11-23 |
Warner-Lambert Company |
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
|
|
US6310060B1
(en)
|
1998-06-24 |
2001-10-30 |
Warner-Lambert Company |
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
|
|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
ES2356886T3
(es)
|
1998-03-31 |
2011-04-14 |
Kyowa Hakko Kirin Co., Ltd. |
Compuestos heterocíclicos nitrogenados.
|
|
DE19853278A1
(de)
|
1998-11-19 |
2000-05-25 |
Aventis Pharma Gmbh |
Substituierte 4-Amino-2-aryl-cyclopenta[d]pyrimidine, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
EP1140067A1
(en)
|
1999-01-07 |
2001-10-10 |
Warner-Lambert Company |
Antiviral method using mek inhibitors
|
|
ATE292462T1
(de)
|
1999-01-07 |
2005-04-15 |
Warner Lambert Co |
Behandlung von asthma anhand von mek-inhibitoren
|
|
US6440966B1
(en)
|
1999-01-13 |
2002-08-27 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as MEK inhibitors
|
|
IL144214A0
(en)
|
1999-01-13 |
2002-05-23 |
Warner Lambert Co |
Benzoheterocycles and their use as mek inhibitors
|
|
US6545030B1
(en)
|
1999-01-13 |
2003-04-08 |
Warner-Lambert Company |
1-heterocycle substituted diarylamines
|
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
|
JP2002534446A
(ja)
|
1999-01-13 |
2002-10-15 |
ワーナー−ランバート・カンパニー |
４′ヘテロアリールジアリールアミン
|
|
WO2000042002A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
|
|
US9534254B1
(en)
|
1999-02-02 |
2017-01-03 |
Abbott Molecular Inc. |
Patient stratification for cancer therapy based on genomic DNA microarray analysis
|
|
US6703020B1
(en)
|
1999-04-28 |
2004-03-09 |
Board Of Regents, The University Of Texas System |
Antibody conjugate methods for selectively inhibiting VEGF
|
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
US6933299B1
(en)
|
1999-07-09 |
2005-08-23 |
Smithkline Beecham Corporation |
Anilinoquinazolines as protein tyrosine kinase inhibitors
|
|
JP2003504363A
(ja)
|
1999-07-09 |
2003-02-04 |
グラクソ グループ リミテッド |
プロテインチロシンキナーゼ阻害剤としてのアニリノキナゾリン類
|
|
TR200200082T2
(tr)
|
1999-07-16 |
2002-04-22 |
Warner-Lambert Company |
MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
|
|
CA2377100A1
(en)
|
1999-07-16 |
2001-01-25 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
|
HK1047895A1
(zh)
|
1999-07-16 |
2003-03-14 |
沃尼尔‧朗伯公司 |
使用mek抑制剂治疗慢性疼痛的方法
|
|
CN1358094A
(zh)
|
1999-07-16 |
2002-07-10 |
沃尼尔·朗伯公司 |
用mek抑制剂治疗慢性疼痛的方法
|
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
|
AU2001247372A1
(en)
|
2000-03-15 |
2001-09-24 |
Warner Lambert Company |
5-amide substituted diarylamines as mex inhibitors
|
|
KR100815681B1
(ko)
|
2000-06-30 |
2008-03-20 |
글락소 그룹 리미티드 |
퀴나졸린 디토실레이트 염 화합물
|
|
DZ3401A1
(fr)
|
2000-07-19 |
2002-01-24 |
Warner Lambert Co |
Esters oxygenes d'acides 4-iodophenylamino benzhydroxamiques
|
|
IL154507A0
(en)
|
2000-08-25 |
2003-09-17 |
Warner Lambert Co |
Process for making n-aryl-anthranilic acids and their derivatives
|
|
ATE346064T1
(de)
|
2000-09-15 |
2006-12-15 |
Vertex Pharma |
Pyrazolverbindungen als protein-kinasehemmer
|
|
EP1337524A1
(en)
|
2000-11-02 |
2003-08-27 |
AstraZeneca AB |
Substituted quinolines as antitumor agents
|
|
DE60203260T2
(de)
|
2001-01-16 |
2006-02-02 |
Glaxo Group Ltd., Greenford |
Pharmazeutische kombination, die ein 4-chinazolinamin und paclitaxel, carboplatin oder vinorelbin enthält, zur behandlung von krebs
|
|
WO2002083139A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
CA2446514A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
|
|
NZ518726A
(en)
|
2001-05-09 |
2004-06-25 |
Warner Lambert Co |
Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
|
|
WO2003022214A2
(en)
|
2001-09-06 |
2003-03-20 |
Millennium Pharmaceuticals, Inc. |
Piperazine and homopiperazine compounds
|
|
CA2468266A1
(en)
|
2001-12-06 |
2003-06-19 |
Merck & Co., Inc. |
Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
JP4469179B2
(ja)
|
2002-01-23 |
2010-05-26 |
バイエル ファーマセチカル コーポレーション |
Ｒｈｏキナーゼ阻害剤としてのピリミジン誘導体
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
TWI338685B
(en)
|
2002-03-13 |
2011-03-11 |
Array Biopharma Inc |
N3 alkylated benzimid azole derivatives as mek inhibitors
|
|
PA8569201A1
(es)
|
2002-03-13 |
2004-05-21 |
Array Biopharma Inc |
"derivados de bencimidazol n3 alquilado como inhibidores de mek" "n3 alkylated benzimimidazole derivatives as mek inhibitors"
|
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
|
CA2480880C
(en)
|
2002-04-08 |
2011-03-22 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
JP4394959B2
(ja)
|
2002-04-08 |
2010-01-06 |
メルク エンド カムパニー インコーポレーテッド |
Ａｋｔ活性の阻害剤
|
|
WO2003086394A1
(en)
|
2002-04-08 |
2003-10-23 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
CA2481241C
(en)
|
2002-04-08 |
2010-07-27 |
Merck & Co., Inc. |
Fused quinoxaline derivatives as inhibitors of akt activity
|
|
EP1503761A1
(en)
|
2002-05-10 |
2005-02-09 |
Neurocrine Biosciences, Inc. |
Substituted piperazines as melanocortin receptor ligands
|
|
US20040102360A1
(en)
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
|
AU2003284981B2
(en)
|
2002-10-30 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
|
CA2506085A1
(en)
|
2002-11-15 |
2004-06-03 |
Ronald Lynn Merriman |
Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
|
|
EP1565446A1
(en)
|
2002-11-28 |
2005-08-24 |
Schering Aktiengesellschaft |
Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
CN1809351A
(zh)
|
2003-04-24 |
2006-07-26 |
麦克公司 |
Akt活性抑制剂
|
|
RS20050885A
(sr)
|
2003-05-30 |
2008-04-04 |
Genentech |
Lečenje sa anti-vegf antitelima
|
|
ATE440825T1
(de)
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
|
|
TW200523262A
(en)
|
2003-07-29 |
2005-07-16 |
Smithkline Beecham Corp |
Inhibitors of AKT activity
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
WO2005044853A2
(en)
|
2003-11-01 |
2005-05-19 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
EP1663994B1
(en)
|
2003-08-05 |
2012-03-07 |
Vertex Pharmaceuticals Incorporated |
Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
|
|
JP2007501821A
(ja)
|
2003-08-12 |
2007-02-01 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｃｆｒアンタゴニストとしてのテトラヒドロキナゾリン誘導体
|
|
EP1666468A4
(en)
|
2003-09-09 |
2007-03-21 |
Ono Pharmaceutical Co |
CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS
|
|
US20050182061A1
(en)
|
2003-10-02 |
2005-08-18 |
Jeremy Green |
Phthalimide compounds useful as protein kinase inhibitors
|
|
EP1682495A1
(en)
|
2003-10-21 |
2006-07-26 |
Warner-Lambert Company LLC |
Polymorphic form of n- (r)-2,3-dihydroxy-propoxy -3,4-d ifluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
|
|
PH12012501891A1
(en)
|
2003-11-21 |
2013-09-02 |
Array Biopharma Inc |
Akt protein kinase inhibitors
|
|
ES2527118T3
(es)
|
2003-12-19 |
2015-01-20 |
Plexxikon Inc. |
Compuestos y procedimientos de desarrollo de moduladores de Ret
|
|
EP1737472B1
(en)
|
2004-03-29 |
2014-08-13 |
University Of South Florida |
Effective treatment of tumors and cancer with triciribine
|
|
JP5213229B2
(ja)
|
2004-04-23 |
2013-06-19 |
エグゼリクシス， インコーポレイテッド |
キナーゼ調節因子および使用方法
|
|
EP1751133B1
(en)
|
2004-04-28 |
2010-04-14 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
|
US20060009360A1
(en)
|
2004-06-25 |
2006-01-12 |
Robert Pifer |
New adjuvant composition
|
|
BRPI0512547A
(pt)
|
2004-06-28 |
2008-03-25 |
Altana Pharma Ag |
pirimidinas
|
|
US20060025074A1
(en)
|
2004-07-30 |
2006-02-02 |
Chih-Ming Liang |
Bluetooth-based headset
|
|
TWM266655U
(en)
|
2004-09-23 |
2005-06-01 |
Blueexpert Technology Corp |
Bluetooth earphone device capable of wirelessly receiving and transmitting stereo sound signal and digital information signal
|
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
|
ATE543821T1
(de)
|
2004-12-28 |
2012-02-15 |
Exelixis Inc |
Ä1h-pyrazoloä3,4-düpyrimidin-4-ylü-piperidin- oder piperazinverbindungen als serin-threonin- kinasemodulatoren (p70s6k, atk1 und atk2) zur behandlung von immunologischen, entzündlichen und proliferativen erkrankungen
|
|
CA2598956A1
(en)
|
2005-02-24 |
2006-08-31 |
Pfizer Products Inc. |
Bicyclic heteroaromatic derivatives useful as anticancer agents
|
|
US20090131474A1
(en)
|
2005-03-03 |
2009-05-21 |
Martino Forino |
Screening methods for protein kinase b inhibitors employing virtual docking approaches and compounds and compositions discovered thereby
|
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
EP1881983B1
(en)
|
2005-05-20 |
2012-01-11 |
Vertex Pharmaceuticals, Inc. |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
UY29610A1
(es)
|
2005-06-21 |
2007-01-31 |
Cancer Rec Tech Ltd |
Aril-alquilaminas y heteroaril-alquilaminas como inhibidores de la quinasa proteínica
|
|
UA95244C2
(ru)
|
2005-06-22 |
2011-07-25 |
Плексикон, Инк. |
Соединения и способ модулирования активности киназ, и показания для их применения
|
|
SI1934174T1
(sl)
|
2005-10-07 |
2011-08-31 |
Exelixis Inc |
Inhibitorji MEK in postopki za njihovo uporabo
|
|
EP1948659A1
(en)
|
2005-10-13 |
2008-07-30 |
Glaxo Group Limited |
Pyrrolopyrimidine derivatives as syk inhibitors
|
|
WO2007060691A2
(en)
*
|
2005-11-23 |
2007-05-31 |
Natco Pharma Limited |
A novel process for the preparation of erlotinib
|
|
WO2007077961A2
(en)
|
2005-12-28 |
2007-07-12 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
|
|
US7814803B2
(en)
|
2006-03-02 |
2010-10-19 |
Nsk Ltd. |
Torque sensor
|
|
JP2009534454A
(ja)
|
2006-04-25 |
2009-09-24 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
KR20090024834A
(ko)
|
2006-07-05 |
2009-03-09 |
인터뮨, 인크. |
Ｃ형 간염 바이러스 복제의 신규 억제제
|
|
GB0613518D0
(en)
|
2006-07-06 |
2006-08-16 |
Phytopharm Plc |
Chemical compounds
|
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
|
US8063050B2
(en)
*
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
NZ573979A
(en)
|
2006-07-06 |
2012-02-24 |
Array Biopharma Inc |
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
|
CA2655675A1
(en)
|
2006-07-06 |
2008-01-10 |
Glaxo Group Limited |
Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
|
|
ATE532789T1
(de)
|
2006-07-06 |
2011-11-15 |
Array Biopharma Inc |
Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
|
|
UA95641C2
(xx)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
|
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
|
WO2008012635A2
(en)
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
|
AR062207A1
(es)
|
2006-08-04 |
2008-10-22 |
Takeda Pharmaceutical |
Derivados de imidazopiridazina inhibidores de quinasas utiles para prevenir y/o tratar el cancer.
|
|
NZ597830A
(en)
*
|
2006-08-25 |
2013-02-22 |
Cougar Biotechnology Inc |
Methods and compositions for treating cancer comprising abiraterone acetate and prednisone
|
|
WO2008094321A2
(en)
|
2006-10-04 |
2008-08-07 |
Universtiy Of South Florida |
Akt sensitization of cancer cells
|
|
CN101332301A
(zh)
*
|
2007-06-26 |
2008-12-31 |
南京医科大学 |
一种抗肿瘤组合物及其应用
|
|
EP2173352B1
(en)
|
2007-07-12 |
2016-09-07 |
University of South Florida |
Inhibitors of akt/pkb with anti-tumor activity
|
|
US8247423B2
(en)
|
2007-07-12 |
2012-08-21 |
Tragara Pharmaceuticals, Inc. |
Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
|
|
US8137919B2
(en)
|
2008-04-10 |
2012-03-20 |
Montefiore Medical Center |
Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib
|
|
WO2010012777A1
(en)
*
|
2008-07-29 |
2010-02-04 |
Nerviano Medical Sciences S.R.L. |
THERAPEUTIC COMBINATION COMPRISING A CDKs INHIBITOR AND AN ANTINEOPLASTIC AGENT
|
|
EP2318377B1
(en)
*
|
2008-07-31 |
2013-08-21 |
Genentech, Inc. |
Pyrimidine compounds, compositions and methods of use
|
|
SG10201507582VA
(en)
*
|
2011-04-01 |
2015-10-29 |
Genentech Inc |
Biomarkers for predicting sensitivity to cancer treatments
|
|
SG10201504303SA
(en)
|
2011-04-01 |
2015-07-30 |
Genentech Inc |
Combinations Of AKT Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
|